J. Jasper Deuring

1.4k total citations
20 papers, 740 citations indexed

About

J. Jasper Deuring is a scholar working on Genetics, Surgery and Oncology. According to data from OpenAlex, J. Jasper Deuring has authored 20 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in J. Jasper Deuring's work include Inflammatory Bowel Disease (10 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Microscopic Colitis (5 papers). J. Jasper Deuring is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Microscopic Colitis (5 papers). J. Jasper Deuring collaborates with scholars based in Netherlands, United States and United Kingdom. J. Jasper Deuring's co-authors include C. Janneke van der Woude, Colin de Haar, Ernst J. Kuipers, Maikel P. Peppelenbosch, Yi Li, Bing Xia, Min Chen, Ron Smits, Monique M. Gerrits and Gwenny M. Fuhler and has published in prestigious journals such as PLoS ONE, Gut and Scientific Reports.

In The Last Decade

J. Jasper Deuring

18 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Jasper Deuring Netherlands 13 284 257 217 211 162 20 740
Lianwen Yuan China 13 177 0.6× 716 2.8× 184 0.8× 102 0.5× 106 0.7× 28 1.0k
Ellen Richmond United States 16 198 0.7× 342 1.3× 406 1.9× 441 2.1× 129 0.8× 36 1.1k
Tim Nebelsiek Germany 5 154 0.5× 349 1.4× 395 1.8× 507 2.4× 93 0.6× 6 987
Daniel A. Giles United States 13 170 0.6× 201 0.8× 265 1.2× 84 0.4× 374 2.3× 19 804
Wing‐Kin Syn United States 16 151 0.5× 380 1.5× 191 0.9× 129 0.6× 649 4.0× 30 1.3k
T. Witthoeft Germany 6 422 1.5× 172 0.7× 321 1.5× 85 0.4× 273 1.7× 12 803
G.C. Naccari Italy 5 320 1.1× 218 0.8× 268 1.2× 144 0.7× 175 1.1× 5 762
Zhi Pang China 14 158 0.6× 269 1.0× 115 0.5× 47 0.2× 134 0.8× 30 655
Renée Baak-Pablo Netherlands 9 129 0.5× 180 0.7× 113 0.5× 214 1.0× 128 0.8× 16 691
Tiantian Sun China 17 109 0.4× 301 1.2× 51 0.2× 302 1.4× 124 0.8× 31 818

Countries citing papers authored by J. Jasper Deuring

Since Specialization
Citations

This map shows the geographic impact of J. Jasper Deuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jasper Deuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jasper Deuring more than expected).

Fields of papers citing papers by J. Jasper Deuring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jasper Deuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jasper Deuring. The network helps show where J. Jasper Deuring may publish in the future.

Co-authorship network of co-authors of J. Jasper Deuring

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jasper Deuring. A scholar is included among the top collaborators of J. Jasper Deuring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jasper Deuring. J. Jasper Deuring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guimarães, Patrícia O., Lucas Petri Damiani, Caio de Assis Moura Tavares, et al.. (2024). Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial. Einstein (São Paulo). 22. eAO0821–eAO0821.
2.
Hetland, Merete Lund, et al.. (2024). Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib. Arthritis Research & Therapy. 26(1). 153–153. 1 indexed citations
3.
Chiorean, Michael, Marco Daperno, Charlie W. Lees, et al.. (2023). Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program. Advances in Therapy. 40(10). 4440–4459. 1 indexed citations
4.
Deuring, J. Jasper, et al.. (2021). Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?. Current Therapeutic Research. 95. 100639–100639. 1 indexed citations
5.
Lees, Charlie W., J. Jasper Deuring, Michael Chiorean, et al.. (2021). Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies. Therapeutic Advances in Gastroenterology. 14. 1088237686–1088237686. 8 indexed citations
6.
Dubinsky, Marla C., Kenji Watanabe, Pauliina Molander, et al.. (2021). Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis—Patients’ and Physicians’ View. Inflammatory Bowel Diseases. 27(11). 1747–1755. 32 indexed citations
7.
Connor, Susan J., et al.. (2021). Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views. JGH Open. 5(9). 1033–1040. 4 indexed citations
8.
Rubin, David T., Ailsa Hart, Remo Panaccione, et al.. (2020). Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians. Inflammatory Bowel Diseases. 27(7). 1096–1106. 25 indexed citations
9.
Deuring, J. Jasper, Meng Li, Wanlu Cao, et al.. (2019). Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease. PLoS ONE. 14(10). e0221924–e0221924. 26 indexed citations
10.
Somasundaram, Rajesh, Sandra Fernandes, J. Jasper Deuring, et al.. (2017). Analysis of SHIP1 expression and activity in Crohn’s disease patients. PLoS ONE. 12(8). e0182308–e0182308. 16 indexed citations
11.
Verhaar, Auke P., et al.. (2014). Dichotomal effect of space flight-associated microgravity on stress-activated protein kinases in innate immunity. Scientific Reports. 4(1). 5468–5468. 14 indexed citations
12.
Parikh, Kaushal, Lu Zhou, Rajesh Somasundaram, et al.. (2014). Suppression of p21Rac Signaling and Increased Innate Immunity Mediate Remission in Crohn’s Disease. Science Translational Medicine. 6(233). 233ra53–233ra53. 26 indexed citations
13.
Deuring, J. Jasper, Gwenny M. Fuhler, Sergey R. Konstantinov, et al.. (2013). Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease. Gut. 63(7). 1081–1091. 102 indexed citations
14.
Deuring, J. Jasper, Colin de Haar, Ernst J. Kuipers, Maikel P. Peppelenbosch, & C. Janneke van der Woude. (2013). The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease. The International Journal of Biochemistry & Cell Biology. 45(4). 798–806. 20 indexed citations
15.
Li, Yi, J. Jasper Deuring, Maikel P. Peppelenbosch, et al.. (2012). STATI, STAT6 and Adenosine 3′,5′-Cyclic Monophosphate (cAMP) Signaling Drive SOCS3 Expression in Inactive Ulcerative Colitis. Molecular Medicine. 18(10). 1412–1419. 18 indexed citations
16.
Li, Yi, J. Jasper Deuring, Maikel P. Peppelenbosch, et al.. (2012). IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis. 33(10). 1889–1896. 112 indexed citations
17.
Deuring, J. Jasper, et al.. (2011). Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding. Biochemical Journal. 441(1). 87–93. 34 indexed citations
18.
Deuring, J. Jasper, Maikel P. Peppelenbosch, Ernst J. Kuipers, C. Janneke van der Woude, & Colin de Haar. (2011). Impeded protein folding and function in active inflammatory bowel disease. Biochemical Society Transactions. 39(4). 1107–1111. 17 indexed citations
19.
20.
Li, Yi, Colin de Haar, Min Chen, et al.. (2009). Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 59(2). 227–235. 282 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianwen Yuan Breakdown of academic impact, for papers by Ellen Richmond Breakdown of academic impact, for papers by Tim Nebelsiek Breakdown of academic impact, for papers by Daniel A. Giles Breakdown of academic impact, for papers by Wing‐Kin Syn Breakdown of academic impact, for papers by T. Witthoeft Breakdown of academic impact, for papers by G.C. Naccari Breakdown of academic impact, for papers by Zhi Pang Breakdown of academic impact, for papers by Renée Baak-Pablo Breakdown of academic impact, for papers by Tiantian Sun
Rankless by CCL
2026